China
Deal focus: Baibu broadens its fabric scope
VC-backed Chinese B2B fabrics trading platform Baibu is making the transition from online marketplace to cloud-based consolidator of the country's fragmented factories
Discipline, operations key to PE success in China - DCP's Liu
Private equity investors in China should prioritize discipline on valuations and operational capabilities rather than spend their time worrying about macroeconomic risks, according to David Liu, chairman and founder of DCP Capital.
FountainVest backs China online ticketing player Maoyan
FountainVest Partners has acquired a significant minority stake in Maoyan Entertainment, a Chinese online ticketing business that completed an IPO in Hong Kong last February.
Hony commits capital to its Hong Kong-listed restaurant platform
Hony Capital has injected HK$780 million ($100 million) into Best Food Holdings, the Hong Kong-listed platform it established in 2016 to make investments in China’s food and beverage industry.
China PE: Tipping point?
Uncertainty continued to weigh on China private equity deal flow last year, leaving plenty of capital sitting on the sidelines waiting to reengage. GPs see diversification as an antidote to competition
Fund focus: Unicorn prepares for turbulence in China's VC space
China-focused venture capital fund-of-funds Unicorn Capital Partners, which has raised $350 million for its latest vehicle, expects consolidation in the tech investment space as underperforming GPs flounder
Chinese cross-border e-commerce platform raises $48m
Inagora - operator of an e-commerce platform that sells Japanese premium products to Chinese customers - has raised JPY5.3 billion ($48m) from SBI holdings, pharmacy chain Sugi Holdings and Xinjin Holding, the cross-border alternative investment arm of...
China's Qiming names Grace Lee as COO
Grace Lee (pictured), has been appointed COO at Qiming Venture Partners, in addition to her existing roles as a partner and CFO – one of several people moves within the Chinese venture capital firm.
BP enters China AI sector
BP has realized its first investment in China’s artificial intelligence (AI) sector by backing energy systems developer R&B Technology through a venture capital arm.
Ascendent surpasses $1b for latest China fund
Ascendent Capital Partners has closed its third China fund with more than $1 billion in commitments, having increased the hard cap.
Ex-Baidu executive raises $29m China business services fund
Longzhong Xinyi, a venture capital firm established by Hailong Xiang (pictured), formerly a senior executive at Baidu, has raised RMB200 million ($29 million) for its debut fund.
Zhiyun raises $144m for chronic disease management platform
Zhiyun Health, a Chinese online healthcare services provider, has raised more than RMB1 billion ($144 million) across two rounds. It describes the investment as the largest private funding event globally in the chronic disease management space.
China's Transcenta secures $100m funding round
Transcenta Holding, a Chinese biotech company formed last year through the merger of MabSpace Bioscience and Hangzhou Just Biotherapeutics (HJB), has raised $100 million in an extended Series B funding round.
Jeneration leads round for China data security provider
DataCloak, a Shenzhen-based data security start-up that employs the zero-trust approach, has raised $13 million in Series A funding led by Jeneration Capital.
Chinese drug developer wins General Atlantic backing
General Atlantic has led a $69 million Series D round of funding for Adagene, a Chinese drug developer with one cancer treatment currently in phase one clinical trials in China and the US.
Lightspeed, Bosch lead $173m round for China's Hesai
Chinese smart sensor maker Hesai Technology has raised a $173 million Series C round led by Germany’s Bosch Group and existing investor Lightspeed China Partners.
China's NextData gets $73m Series C
Tencent Holdings and XiangHe Capital have led a $73 million Series C round for China-based cybersecurity services provider NextData.
China’s CF PharmTech raises $90m Series E
CF PharmTech, a Chinese devices maker focused on respiratory health, has raised $90 million in Series E funding led by local private equity investor New Alliance Capital.
Chinese genetic testing player secures $115m round
Geneseeq, a Chinese genetic testing company that focuses on treatments for cancer, has raised RMB800 million ($115 million) in a funding round led by state-owned China Reform Holding Corporation.
Chinese biopharma player secures $100m Series B
Elpiscience, a Shanghai-based biopharmaceutical company has completed a $100 million Series B round of funding led by specialist healthcare GP Hyfinity Investments.
Talking points: 2019 in quotes
What industry participants had to say at AVCJ events on co-investment, technology opportunities in Vietnam, what LPs want to hear from GPs, Indian buyouts, long-dated funds, and late-stage deals in China deployment during times of uncertainty, responding...
China's Hua Capital buys chip unit from US-listed Synaptics
Hua Capital, a Chinese investment firm that primarily focuses on the semiconductor industry, has agreed to acquire an Asia-based mobile LCD chip business from US-listed Synaptics for $120 million in cash.
Carlyle backs Chinese apartment operator Anxin
The Carlyle Group has acquired a significant minority stake in Anxin Apartment, a Chinese serviced apartment operator that specializes in affordable housing for corporate clients.
Deal focus: China's Benlai takes a different approach to group buying
Community group buying businesses are beginning to struggle in China despite considerable VC investment. Fresh produce retailer Benlai believes its online-to-offline hybrid model is more sustainable